Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 06, 2022 10:52am
$RVV $RVVTF - Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-141800196.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 06, 2022 10:18am
New Press Release - Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on...
read article.
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Oct 04, 2022 9:47am
RE:This should be a good day for RVV
Hahaha, with tears...
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 04, 2022 7:51am
This should be a good day for RVV
Fingers crossed
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 03, 2022 9:17am
A $0.40 bid would be even better
While you are at it!
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on Oct 03, 2022 9:00am
RVV pumpers and bashers are the same people!
Get a life people!
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Sep 30, 2022 8:24am
you want an easy 10x
follow $STSS ULTRALOW waste syringes with production starting this quarter only 9 million cap raised 24 milllion pre money and new IPO THIS YEAR ..gift
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 29, 2022 8:04pm
Revive Hits a Snag? That didn’t happen folks ! $$$$$$$ !!
#Bucillamine https://internetstockreview.com/revive-hits-a-snag/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 29, 2022 7:48am
Revive Therapeutics To Schedule DSMB Meeting In Lieu Of FDA
#Bucillamine https://thedalesreport.com/psychedelics/revive-therapeutics-to-forge-ahead-with-dsmb-meeting-despite-fda-decision/
(11)
•••
Batemanwanabe
X
View Profile
View Bullboard History
Post by
Batemanwanabe
on Sep 29, 2022 4:35am
It's going to get real,,,, real fast
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170062599
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Comment by
1ottrunner
on Sep 28, 2022 9:59am
RE:Probably means one hell of a buying
Some people will dig through a turd for days looking for a diamond and end up with a peanut.
(876)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Sep 28, 2022 9:47am
Probably means one hell of a buying
opportunity ! They are going to make them work for it is my guess which probably is the correct thing to do ! the FDA has advised the Company to submit a meeting request to
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Sep 28, 2022 8:33am
RE:$RVV - Update
Not sure if this means the data wasn't statistically significant for PCR reduction OR that FDA doesn't accept that as a valid endpoint. FDA initial guidance 2yrs ago was not to look at
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 28, 2022 7:05am
$RVV - Update
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-110000648.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 28, 2022 7:00am
New Press Release - Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >